In vitro enzymatic assays have demonstrated that CBX3 selectively potentiates the lactylation activity of P300 over its acetylation activity; notably, CBX3 is also currently the most well-documented lactylation ‘reader’ within the context of glioma. The gene discussed is CBX3; the disease is central nervous system cancer.